Serum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate

Bahceci, MithatPasa, SemirAkay, Hatice O.Tuzcu, AlpaslanTumer, CemilGokalp, Deniz2024-09-182024-09-1820080015-02821556-5653https://doi.org/10.1016/j.fertnstert.2007.04.014https://hdl.handle.net/20.500.12483/13241Baseline and stimulated nitric oxide (NO) levels were higher, whereas baseline arterial diameter, FMD-stimulated NO increment, and arterial dilatation ratio were lower in Sheehan syndrome (SS) patients than in control subjects. After combination therapy consisting of prednisolone, L-thyroxine, and conjugated estrogen, baseline and stimulated NO levels of SS remained as high, but FMID-stimulated NO, NO increment ratio, and arterial dilatation ratio increased with treatment. (Fertil Steril (R) 2008;89:995-7. (c) 2008 by American Society for Reproductive Medicine.)eninfo:eu-repo/semantics/openAccessL-ArginineSynthaseReplacementNecrosisSerum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetateEditorial Material89499599710.1016/j.fertnstert.2007.04.014175824072-s2.0-41749123745Q1WOS:000255250100036Q1